You are here

Article Text

Article menu
Download PDFPDF
Midwifery
Randomised controlled trial
Immediate preterm delivery for pregnancy hypertension increases risk of neonatal respiratory distress
  1. Rita J Nutt
  1. Department of Nursing, Salisbury University, Salisbury, Maryland, USA
  1. Correspondence to: Rita J Nutt, Department of Nursing, Salisbury University, 1101 Camden Ave, Devilbiss Hall 210, Salisbury, MD 21801, USA; rjnutt{at}salisbury.edu

https://doi.org/10.1136/eb-2015-102155

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Broekhuijsen K, van Baaren GJ, van Pampus MG, et al., HYPITAT-II study group. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015;385:2492–501.OpenUrlCrossRefPubMed

    Implications for practice and research

    • Study findings may change current management patterns for mild hypertensive patients, necessitating an increase in antepartum rooms for expectant management.

    • Replication of this study is needed to enhance the body of evidence and further validate the findings.

    Context

    Hypertensive disorders in pregnancy are on the rise and continue to be a leading cause of maternal and infant morbidity and mortality worldwide.1 Management of these disorders in preterm gestations is complicated by the need to balance the wellbeing of both mother and neonate. Immediate delivery likely reduces the risk of adverse maternal outcomes but …

    View Full Text

    Footnotes

    • Competing interests None declared.